In silico studies on potential MCF-7 inhibitors: a combination of pharmacophore and 3D-QSAR modeling, virtual screening, molecular docking, and pharmacokinetic analysis

References

• Ananthula, R. S., Ravikumar, M., Mahmood, S. K., & Kumar, M. N. S. P. (2012). Insights from ligand and structure based methods in virtual screening of selective Ni-peptide deformylase inhibitors. Journal of Molecular Modeling, 18, 693–708. doi:10.1007/s00894-011-1068-6
   PubMed Web of Science ®Google Scholar
• Appeldoorn, C. C. M., Bonnefoy, A., Lutters, B. C. H., Daenens, K., van Berkel, T. J. C., Hoylaerts, M. F., & Biessen, E. A. L. (2005). Gallic acid antagonizes P-selectin–mediated platelet–leukocyte interactions: Implications for the French paradox. Circulation, 111, 106–112. doi:10.1161/01.CIR.0000151307.10576.02.
   PubMed Web of Science ®Google Scholar
• Badhani, B., Sharma, N., & Kakkar, R. (2015). Gallic acid: A versatile antioxidant with promising therapeutic and industrial applications. RSC Advances, 5, 27540–27557. doi:10.1039/C5RA01911G.
   Web of Science ®Google Scholar
• Barbosa, E. G., Bega, L. A., Beatriz, A., Sarkar, T., Hamel, E., do Amaral, M. S., & de Lima, D. P. (2009). A diaryl sulfide, sulfoxide, and sulfone bearing structural similarities to combretastatin A-4. European Journal of Medicinal Chemistry, 44, 2685–2688. doi:10.1016/j.ejmech.2008.12.018
   PubMed Web of Science ®Google Scholar
• Barrett, I., Meegan, M. J., Hughes, R. B., Carr, M., Knox, A. J. S., Artemenko, N., … Lloyd, D. G. (2008). Synthesis, biological evaluation, structural–activity relationship, and docking study for a series of benzoxepin-derived estrogen receptor modulators. Bioorganic and Medicinal Chemistry, 16, 9554–9573. doi:10.1016/j.bmc.2008.09.035.
   PubMed Web of Science ®Google Scholar
• Blanke, C. D., Kasimis, B., Schein, P., Capizzi, R., & Kurman, M. (1997). Phase II study of trimetrexate, fluorouracil, and leucovorin for advanced colorectal cancer. Journal of Clinical Oncology, 15, 915–920. http://jco.ascopubs.org/content/15/3/915.short
   PubMed Web of Science ®Google Scholar
• Blecha, J. E., Anderson, M. O., Chow, J. M., Guevarra, C. C., Pender, C., Penaranda, C., … Berkman, C. E. (2007). Inhibition of IGF-1R and lipoxygenase by nordihydroguaiaretic acid (NDGA) analogs. Bioorganic and Medicinal Chemistry Letters, 17, 4026–4029. doi:10.1016/j.bmcl.2007.04.092
   PubMed Web of Science ®Google Scholar
• Bosch-Barrera, J., & Menendez, J. A. (2015). Silibinin and STAT3: A natural way of targeting transcription factors for cancer therapy. Cancer Treatment Review, 41, 540–546. doi:10.1016/j.ctrv.2015.04.008. PMID 25944486
   PubMed Web of Science ®Google Scholar
• Bourderioux, A., Nauš, P., Perlíková, P., Pohl, R., Pichová, I., Votruba, I., & Džubák, Petr (2011). Synthesis and significant cytostatic activity of 7-Hetaryl-7-deazaadenosines. Journal of Medicinal Chemistry, 54, 5498–5507. doi:10.1021/jm2005173.
   PubMed Web of Science ®Google Scholar
• Bowen, D., Johnson, D. H., Southerland, W. M., Hughes, D. E., & Hawkins, M. Jr. (1999). Selectivity in human breast cancer and human bone marrow using trimetrexate in combination with 5-fluorouracil. Anticancer Research, 19, 3837–3840. http://www.ncbi.nlm.nih.gov/pubmed/10628320
   PubMed Web of Science ®Google Scholar
• Cavalli, A., Poluzzi, E., De Ponti, F., & Recanatini, M. (2002). Toward a pharmacophore for drugs inducing the long QT syndrome: Insights from a CoMFA study of HERG K(+) channel blockers. Journal of Medicinal Chemistry, 45, 3844–3853. doi:10.1021/jm0208875
   PubMed Web of Science ®Google Scholar
• Chattopadhyay, S., Bisaria, V. S., Panda, A. K., & Srivastava, A. K. (2004). Cytotoxicity of in vitro produced podophyllotoxin from podophyllum hexandrum on human cancer cell line. Natural Product Research, 18, 51–57. doi:10.1080/1057563031000122095
   PubMed Web of Science ®Google Scholar
• Chen, H.-M., Wu, Y.-C., Chia, Y.-C., Chang, F.-R., Hsu, H.-K., Hsieh, Y.-C., … Yuan, S. -S. (2009). Gallic acid, a major component of Toona sinensis leaf extracts, contains a ROS-mediated anti-cancer activity in human prostate cancer cells. Cancer Letters, 286, 161–171. doi:10.1016/j.canlet.2009.05.040
   PubMed Web of Science ®Google Scholar
• Chia, Y. C., Rajbanshi, R., Calhoun, C., & Chiu, R. H. (2010). Anti-neoplastic effects of gallic acid, a major component of Toona sinensis leaf extract, on oral squamous carcinoma cells. Molecules, 15, 8377–8389. doi:10.3390/molecules15118377
   PubMed Web of Science ®Google Scholar
• Choi, E. J. (2007). Hesperetin induced G1-phase cell cycle arrest in human breast cancer MCF-7 cells: Involvement of CDK4 and p21. Nutrition and Cancer, 59, 115–119. doi:10.1080/01635580701419030
   PubMed Web of Science ®Google Scholar
• De Almeida, J. S. F. D., Guizado, T. R. C., Guimarães, A. P., Ramalho, T. C., Gonçalves, A. S., De Koning, M. C., & França, T. C. C. (2016). Docking and molecular dynamics studies of peripheral site ligand–oximes as reactivators of sarin-inhibited human acetylcholinesterase. Journal of Biomolecular Structure and Dynamics. Advance online publication. doi:10.1080/07391102.2015.1124807
   PubMed Web of Science ®Google Scholar
• De Martino, G., La Regina, G., Coluccia, A., Edler, M. C., Barbera, M. C., Brancale, A., … Silvestri, R. (2004). Arylthioindoles, Potent Inhibitors of Tubulin Polymerization. Journal of Medicinal Chemistry, 47, 6120–6123. doi:10.1021/jm049360d.
   PubMed Web of Science ®Google Scholar
• De Ponti, F., Poluzzi, E., & Montanaro, N. (2001). Organising evidence on QT prolongation and occurrence of Torsades de Pointes with non-antiarrhythmic drugs: a call for consensus. European Journal of Clinical Pharmacology, 57, 185–209. doi:10.1007/s002280100290.
   PubMed Web of Science ®Google Scholar
• Deora, G. S., Joshi, P., Rathore, V., Kumar, K. L., Ohlyan, R., & Kandale, A. (2013). Pharmacophore modeling and 3D QSAR analysis of isothiazolidinedione derivatives as PTP1B inhibitors. Medicinal Chemistry Research, 22, 3478–3484. doi:10.1007/s00044-012-0349-7
   Web of Science ®Google Scholar
• Desai, A., & Mitchison, T. J. (1997). Microtubule polymerization dynamics. Annual Review of Cell and Developmental Biology, 13, 83–117. doi:10.1146/annurev.cellbio.13.1.83
   PubMed Web of Science ®Google Scholar
• Dixon, S. L., Smondyrev, A. M., & Rao, S. N. (2006). PHASE: A novel approach to pharmacophore modeling and 3D database searching. Chemical Biology and Drug Design, 67, 370–372. doi:10.1111/j.1747-0285.2006.00384.x
   PubMed Web of Science ®Google Scholar
• Dixon, S. L., Smondyrev, A. M., Knoll, E. H., Rao, S. N., Shaw, D. E., & Friesner, R. A. (2006). PHASE: A new engine for pharmacophore perception, 3D QSAR model development, and 3D database screening: 1. Methodology and preliminary results. Journal of Computer-Aided Molecular Design, 20, 647–671. doi:10.1007/s10822-006-9087-6
   PubMed Web of Science ®Google Scholar
• Drwal, M. N., & Griffith, R. (2013). Combination of ligand- and structure-based methods in virtual screening. Drug Discovery Today: Technologies, 10, e395–e401. doi:10.1016/j.ddtec.2013.02.002
   PubMedGoogle Scholar
• Duffy, E. M., & Jorgensen, W. L. (2000). Prediction of properties from simulations: Free energies of solvation in hexadecane, octanol, and water. Journal of the American Chemical Society, 122, 2878–2888. doi:10.1021/ja993663t
   Web of Science ®Google Scholar
• Elango, S., Balwas, R., & Padma, V. V. (2011). Gallic acid isolated from pomegranate peel extract induces reactive oxygen species mediated apoptosis in A549 cell line. Journal of Cancer Therapy, 2, 638–645. doi:10.4236/jct.2011.25085
   Google Scholar
• Faried, A., Kurnia, D., Faried, L. S., Usman, N., Miyazaki, T., Kato, H., & Kuwano, H. (2007). Anticancer effects of gallic acid isolated from Indonesian herbal medicine, Phaleria macrocarpa (Scheff.) Boerl, on human cancer cell lines. International Journal of Oncology, 30, 605–613. doi:10.3892/ijo.30.3.605
   PubMed Web of Science ®Google Scholar
• Flynn, B. L., Flynn, G. P., Hamel, E., & Jung, M. K. (2001). The synthesis and tubulin binding activity of thiophene-based analogues of combretastatin A-4. Bioorganic and Medicinal Chemistry Letters, 11, 2341–2343. doi:10.1016/S0960-894X(01)00436-X
   PubMed Web of Science ®Google Scholar
• Forgo, P., Zupkó, I., Molnár, J., Vasas, A., Dombi, G., & Hohmann, J. (2012). Bioactivity-guided isolation of antiproliferative compounds from Centaurea jacea L. Fitoterapia, 83, 921–925. doi:10.1016/j.fitote.2012.04.006
   PubMed Web of Science ®Google Scholar
• Fossella, F. V., Lynch, T., & Shepherd, F. A. (2002). Second line chemotherapy for NSCLC: Establishing a gold standard. Lung Cancer, 38, 5–12. doi:10.1016/S0169-5002(02)00167-8
   PubMed Web of Science ®Google Scholar
• Frantz, S. (2004). Better antibiotics through chemistry. Nature Reviews Drug Discovery, 3, 900–901. doi:10.1038/nrd1574
   PubMed Web of Science ®Google Scholar
• Giftson, J. S., Jayanthi, S., & Nalini, N. (2010). Chemopreventive efficacy of gallic acid, an antioxidant and anticarcinogenic polyphenol, against 1, 2-dimethyl hydrazine induced rat colon carcinogenesis. Investigational New Drugs, 28, 251–259. doi:10.1007/s10637-009-9241-9
   PubMed Web of Science ®Google Scholar
• Golbraikh, A., & Tropsha, A. (2002). Beware of q2!. Journal of Molecular Graphics and Modelling, 20, 269–276. doi:10.1016/S1093-3263(01)00123-1
   PubMed Web of Science ®Google Scholar
• González-Abuín, N., Martínez-Micaelo, N., Margalef, M., Blay, M., Arola-Arnal, A., Muguerza, B., … Pinent, M. (2014). A grape seed extract increases active glucagon-like peptide-1 levels after an oral glucose load in rats. Food and Function, 5, 2357–2364. doi:10.1039/c4fo00447g
   PubMed Web of Science ®Google Scholar
• Gray, A. L., Stephens, C. A., Bigelow, R. L., Coleman, D. T., & Cardelli, J. A. (2014). The polyphenols (−)-epigallocatechin-3-gallate and luteolin synergistically inhibit TGF-β-induced myofibroblast phenotypes through RhoA and ERK inhibition. PLoS One, 9, e109208. doi:10.1371/journal.pone.0109208
   PubMed Web of Science ®Google Scholar
• Gulyaeva, N., Zaslavsky, A., Lechner, P., Chlenov, M., McConnell, O., Chait, A., & Zaslavsky, B. (2003). Relative hydrophobicity and lipophilicity of drugs measured by aqueous two-phase partitioning, octanol-buffer partitioning and HPLC. A simple model for predicting blood–brain distribution. European Journal of Medicinal Chemistry, 38, 391–396. doi:10.1016/S0223-5234(03)00044-8
   PubMed Web of Science ®Google Scholar
• Hoffman, D. B., Pearson, C. G., Yen, T. J., Howell, B. J., & Salmon, E. D. (2001). Microtubule-dependent changes in assembly of microtubule motor proteins and mitotic spindle checkpoint proteins at PtK1 kinetochores. Molecular Biology of the Cell, 12, 1995–2009. doi:10.1091/mbc.12.7.1995
   PubMed Web of Science ®Google Scholar
• Hou, T., & Xu, X. (2004). Recent development and application of virtual screening in drug discovery: An overview. Current Pharmaceutical Design, 10, 1011–1033. doi:10.2174/1381612043452721
   PubMed Web of Science ®Google Scholar
• Hsiang, C.-Y., Hseu, Y.-C., Chang, Y.-C., Kumar, K. J. S., Ho, T.-Y., & Yang, H.-L. (2013). Toona sinensis and its major bioactive compound gallic acid inhibit LPS-induced inflammation in nuclear factor-κB transgenic mice as evaluated by in vivo bioluminescence imaging. Food Chemistry, 136, 426–434. doi:10.1016/j.foodchem.2012.08.009
   PubMed Web of Science ®Google Scholar
• Huang, P.-J., Hseu, Y.-C., Lee, M.-S., Kumar, K. J. S., Wu, C.-R., Hsu, L.-S., … Yang, H. -L. (2012). In vitro and in vivo activity of gallic acid and Toona sinensis leaf extracts against HL-60 human premyelocytic leukemia. Food and Chemical Toxicology, 50, 3489–3497. doi:10.1016/j.fct.2012.06.046
   PubMed Web of Science ®Google Scholar
• Hummel, C. W., Geiser, A. G., Bryant, H. U., Cohen, I. R., Dally, R. D., Fong, K. C., … Dodge, J. A. (2005). A selective estrogen receptor modulator designed for the treatment of uterine leiomyoma with unique tissue specificity for uterus and ovaries in rats. Journal of Medicinal Chemistry, 48, 6772–6775. doi:10.1021/jm050723z
   PubMed Web of Science ®Google Scholar
• Irwin, J. J., & Shoichet, B. K. (2005). ZINC − A free database of commercially available compounds for virtual screening. Journal of Chemical Information and Modeling, 45, 177–182. doi:10.1021/ci049714+
   PubMed Web of Science ®Google Scholar
• Irwin, J. J., Sterling, T., Mysinger, M. M., Bolstad, E. S., & Coleman, R. G. (2012). ZINC: A free tool to discover chemistry for biology. Journal of Chemical Information and Modeling, 52, 1757–1768. doi:10.1021/ci3001277
   PubMed Web of Science ®Google Scholar
• Jassem, J., Kosmidis, P., Ramlau, R., Zarogoulidis, K., Novakova, L., Breton, J., … Lefresne, F. (2003). Oral vinorelbine in combination with cisplatin: A novel active regimen in advanced non-small-cell lung cancer. Annals of Oncology, 14, 1634–1639. doi:10.1093/annonc/mdg455
   PubMed Web of Science ®Google Scholar
• Jiang, Q., Payton-Stewart, F., Elliott, S., Driver, J., Rhodes, L. V., Zhang, Q., … Wang, G. (2010). Effects of 7-O substitutions on estrogenic and anti-estrogenic activities of daidzein analogues in MCF-7 breast cancer cells. Journal of Medicinal Chemistry, 53, 6153–6163. doi:10.1021/jm100610w
   PubMed Web of Science ®Google Scholar
• Jordan, M. A., & Wilson, L. (2004). Microtubules as a target for anticancer drugs. Nature Reviews Cancer, 4, 253–265. doi:10.1038/nrc1317
   PubMed Web of Science ®Google Scholar
• Jorgensen, W. L., & Duffy, E. M. (2000). Prediction of drug solubility from Monte Carlo simulations. Bioorganic and Medicinal Chemistry Letters, 10, 1155–1158. doi:10.1016/S0960-894X(00)00172-4
   PubMed Web of Science ®Google Scholar
• Jorgensen, W. L., & Duffy, E. M. (2002). Prediction of drug solubility from structure. Advanced Drug Delivery Reviews, 54, 355–366. doi:10.1016/S0169-409X(02)00008-X
   PubMed Web of Science ®Google Scholar
• Kakkar, R., Arora, R., Gahlot, P., & Gupta, D. (2014). An insight into pyruvate dehydrogenase kinase (PDHK) inhibition through pharmacophore modeling and QSAR studies. Journal of Computational Science, 5, 558–567. doi:10.1016/j.jocs.2014.04.006
   Web of Science ®Google Scholar
• Kamal, A., Reddy, T. S., Polepalli, S., Shalini, N., Reddy, V. G., Rao, A. V. S., … Shankaraiah, N. (2014). Synthesis and biological evaluation of podophyllotoxin congeners as tubulin polymerization inhibitors. Bioorganic and Medicinal Chemistry, 22, 5466–5475. doi:10.1016/j.bmc.2014.07.031
   PubMed Web of Science ®Google Scholar
• Kamal, A., Kumar, G. B., Vishnuvardhan, M. V., Shaik, A. B., Reddy, V. S., Mahesh, R., … Kapure, J. S. (2015). Synthesis of phenstatin/isocombretastatin– chalcone conjugates as potent tubulin polymerization inhibitors and mitochondrial apoptotic inducers. Organic and Biomolecular Chemistry, 13, 3963–3981. doi:10.1039/c4ob02606c
   PubMed Web of Science ®Google Scholar
• Kelly, W. K., Zhu, A. X., Scher, H., Curley, T., Fallon, M., Slovin, S., … Rocchetti, M. (2003). Dose escalation study of intravenous estramustine phosphate in combination with paclitaxel and carboplatin in patients with advanced prostate cancer. Clinical Cancer Research, 9, 2098–2107. Retrieved from http://clincancerres.aacrjournals.org/content/9/6/2098.long
   PubMed Web of Science ®Google Scholar
• Khaledi, H., Alhadi, A. A., Yehye, W. A., Ali, H. M., Abdulla, M. A., & Hassandarvish, P. (2011). Antioxidant, Cytotoxic Activities, and Structure-Activity Relationship of Gallic Acid-based Indole Derivatives. Archiv der Pharmazie Chemistry in Life Science, 344, 703–709. doi:10.1002/ardp.201000223
   PubMed Web of Science ®Google Scholar
• Kubinyi, H. (2008) Comparative Molecular Field Analysis (CoMFA). In J.Gasteiger (Ed.), Handbook of Chemoinformatics – From data to knowledge. Weinheim: Wiley-VCH Verlag GmbH. doi:10.1002/9783527618279.ch44d
   Google Scholar
• Kumari, T., Issar, U., & Kakkar, R. (2014). Docking modes of BB-3497 into the PDF active site – A comparison of the pure MM and QM/MM based docking strategies. Current Computer-Aided Drug Design, 10, 315–326. doi:10.2174/157340991004150518145522
   PubMed Web of Science ®Google Scholar
• Lecumberri, E., Dupertuis, Y. M., Miralbell, R., & Pichard, C. (2013). Green tea polyphenol epigallocatechin-3-gallate (EGCG) as adjuvant in cancer therapy. Clinical Nutrition, 32, 894–903. doi:10.1016/j.clnu.2013.03.008
   PubMed Web of Science ®Google Scholar
• Lee, D. Y.-W., & Liu, Y. (2003). Molecular structure and stereochemistry of silybin A, silybin B, isosilybin A, and isosilybin B, isolated from Silybum marianum (milk thistle). Journal of Natural Products, 66, 1171–1174. doi:10.1021/np030163b
   PubMed Web of Science ®Google Scholar
• Li, Y., Wang, Y., & Zhang, F. (2010). Pharmacophore modeling and 3D-QSAR analysis of phosphoinositide 3-kinase p110α inhibitors. Journal of Molecular Modeling, 16, 1449–1460. doi:10.1007/s00894-010-0659-y
   PubMed Web of Science ®Google Scholar
• Lipinski, C. A., Lombardo, F., Dominy, B. W., & Feeney, P. J. (1997). Experimental and computational approaches to estimate solubility and permeability in drug discovery and development settings. Advanced Drug Delivery Reviews, 23, 3–25. doi:10.1016/S0169-409X(96)00423-1
   Web of Science ®Google Scholar
• Lipinski, C. A., Lombardo, F., Dominy, B. W., & Feeney, P. J. (2001). Experimental and computational approaches to estimate solubility and permeability in drug discovery and development settings. Advanced Drug Delivery Reviews, 46, 3–26. doi:10.1016/S0169-409X(00)00129-0
   PubMed Web of Science ®Google Scholar
• Locatelli, C., Rosso, R., Santos-Silva, M. S., de Souza, C. A., Licinio, M. A., Leal, P., … Creczynsk-Pasa, T. B. (2008). Ester derivatives of gallic acid with potential toxicity toward L1210 leukemia cells. Bioorganic and Medicinal Chemistry, 16, 3791–3799. doi:10.1016/j.bmc.2008.01.049
   PubMed Web of Science ®Google Scholar
• Madlener, S., Illmer, C., Horvath, Z., Saiko, P., Losert, A., Herbacek, I., … Szekeres, T. (2007). Gallic acid inhibits ribonucleotide reductase and cyclooxygenases in human HL-60 promyelocytic leukemia cells. Cancer Letters, 245, 156–162. doi:10.1016/j.canlet.2006.01.001
   PubMed Web of Science ®Google Scholar
• Merzouki, A., Buschmann, M. D., Jean, M., Young, R. S., Liao, S., Gal, S., … Slilaty, S. N. (2012). Adva-27a, a novel podophyllotoxin derivative found to be effective against multidrug resistant human cancer cells. Anticancer Research, 32, 4423–4432. Retrieved from http://ar.iiarjournals.org/content/32/10/4423.long
   PubMed Web of Science ®Google Scholar
• Okouneva, T., Hill, B. T., Wilson, L., & Jordan, M. A. (2003). The effects of vinflunine, vinorelbine, and vinblastine on centromere dynamics. Molecular Cancer Therapeutics, 2, 427–436. Retrieved from http://mct.aacrjournals.org/content/2/5/427.long
   PubMed Web of Science ®Google Scholar
• Palacios, C., Cespon, C., Martin De La Vega, C., Roy, G., Serrano, A., Salinas, M., & Gonzalez-Porque, P. (2002). Lauryl gallate inhibits the activity of protein tyrosine kinase c-Src purified from human platelets. Journal of Enzyme Inhibition and Medicinal Chemistry, 16, 527–533. doi:10.1080/14756360127567
   Web of Science ®Google Scholar
• Patel, K. J., Lee, C., Tan, Q., & Tannock, I. F. (2013). Use of the proton pump inhibitor pantoprazole to modify the distribution and activity of doxorubicin: A potential strategy to improve the therapy of solid tumors. Clinical Cancer Research, 19, 6766–6776. doi:10.1158/1078-0432.CCR-13-0128
   PubMed Web of Science ®Google Scholar
• Pellegrina, C. D., Padovani, G., Mainente, F., Zoccatelli, G., Bissoli, G., Mosconi, S., … Chignola, R. (2005). Anti-tumour potential of a gallic acid-containing phenolic fraction from Oenothera biennis. Cancer Letters, 226, 17–25. doi:10.1016/j.canlet.2004.11.033
   PubMed Web of Science ®Google Scholar
• Petit, J., Meurice, N., Kaiser, C., & Maggiora, G. (2012). Softening the rule of five – Where to draw the line? Bioorganic and Medicinal Chemistry, 20, 5343–5351. doi:10.1016/j.bmc.2011.11.064
   PubMed Web of Science ®Google Scholar
• Pineda, P., Kanter, A., McIvor, R. S., Benkovic, S. J., Rosowsky, A., & Wagner, C. R. (2003). Dihydrofolate reductase mutant with exceptional resistance to methotrexate but not to trimetrexate. Journal of Medicinal Chemistry, 46, 2816–2818. doi:10.1021/jm034057i
   PubMed Web of Science ®Google Scholar
• Prager-Khoutorsky, M., Goncharov, I., Rabinkov, A., Mirelman, D., Geiger, B., & Bershadsky, A. D. (2007). Allicin inhibits cell polarization, migration and division via its direct effect on microtubules. Cell Motility and the Cytoskeleton, 64, 321–337. doi:10.1002/cm.20185
   PubMed Web of Science ®Google Scholar
• Prakasham, A. P., Saxena, A. K., Luqman, S., Chanda, D., Kaur, T., Gupta, A., & Negi, A. S. (2012). Synthesis and anticancer activity of 2-benzylidene indanones through inhibiting tubulin polymerization. Bioorganic and Medicinal Chemistry, 20, 3049–3057. doi:10.1016/j.bmc.2012.02.057
   PubMed Web of Science ®Google Scholar
• Ravelli, R. B. G., Gigant, B., Curmi, P. A., Jourdain, I., Lachkar, S., Sobel, A., & Knossow, M. (2004). Insight into tubulin regulation from a complex with colchicine and a stathmin-like domain. Nature, 428, 198–202. doi:10.1038/nature02393
   PubMed Web of Science ®Google Scholar
• Ray, S. (2012). QSAR modeling of antitmycobacterial activities of N-benzylsalicylamides and N-benzylsalicylthioamides derivatives against Mycobacterium kansasii CNCTC My (6509/96) using stepwise and PLS Method. International Journal of ChemTech Research, 4, 41–47. Retrieved from http://sphinxsai.com/2012/chem/CHEM/CT=08%2841-47%29JM12.pdf
   Google Scholar
• Reddy, D. M., Srinivas, J., Chashoo, G., Saxena, A. K., & Kumar, H. M. S. (2011). 4β-[(4-Alkyl)-1,2,3-triazol-1-yl] podophyllotoxins as anticancer compounds: Design, synthesis and biological evaluation. European Journal of Medicinal Chemistry, 46, 1983–1991. doi:10.1016/j.ejmech.2011.02.016
   PubMed Web of Science ®Google Scholar
• Rojas-Sepúlveda, A. M., Mendieta-Serrano, M., Mojica, M. Y., Salas-Vidal, E., Marquina, S., Villarreal, M. L., … Alvarez, L. (2012). Cytotoxic podophyllotoxin type-lignans from the steam bark of Bursera fagaroides var. fagaroides. Molecules, 17, 9506–9519. doi:10.3390/molecules17089506
   PubMed Web of Science ®Google Scholar
• Rossi, A., Gridelli, C., Gebbia, V., Rosati, G., Tortoriello, A., Maione, P., … Manzione, L. (2003). Single agent vinorelbine as first-line chemotherapy in elderly patients with advanced breast cancer. Anticancer Research, 23, 1657–1664. Retrieved from http://www.ncbi.nlm.nih.gov/pubmed/12820437
   PubMed Web of Science ®Google Scholar
• Rubis, B., Kaczmarek, M., Szymanowska, N., Galezowska, E., Czyrski, A., Juskowiak, B., … Rybczynska, M. (2009). The biological activity of G-quadruplex DNA binding papaverine-derived ligand in breast cancer cells. Investigational New Drugs, 27, 289–296. doi:10.1007/s10637-008-9173-9
   PubMed Web of Science ®Google Scholar
• Ruenitz, P. C., Arrendale, R. F., Schmidt, W. F., Thompson, C. B., & Nanavati, N. T. (1989). Phenolic metabolites of clomiphene: [(E, Z)-2-[4-(1,2-diphenyl-2-chlorovinyl)phenoxy]ethyl]diethylamine. Preparation, electrophilicity, and effects in MCF 7 breast cancer cells. Journal of Medicinal Chemistry, 32, 192–197. doi:10.1021/jm00121a035
   PubMed Web of Science ®Google Scholar
• Rundfeldt, C., Socała, K., & Wlaź, P. (2010). The atypical anxiolytic drug, tofisopam, selectively blocks phosphodiesterase isoenzymes and is active in the mouse model of negative symptoms of psychosis. Journal of Neural Transmission, 117, 1319–1325. doi:10.1007/s00702-010-0507-3
   PubMed Web of Science ®Google Scholar
• Sandler, A. B. (2003). Chemotherapy for small cell lung cancer. Seminars in Oncology, 30, 9–25. doi:10.1053/sonc.2003.50012
   PubMed Web of Science ®Google Scholar
• Santos-Garcia, L., Assis, L. C., Silva, D. R., Ramalho, T. C., & Da Cunha, E. F. F. (2016). QSAR analysis of nicotinamidic compounds and design of potential Bruton’s tyrosine kinase (Btk) inhibitors. Journal of Biomolecular Structure and Dynamics, 34, 1421–1440. doi:10.1080/07391102.2015.1070750.
   PubMed Web of Science ®Google Scholar
• Saxena, H. O., Faridi, U., Srivastava, S., Kumar, J. K., Darokar, M. P., Luqman, S., … Khanuja, S. P. (2008). Gallic acid-based indanone derivatives as anticancer agents. Bioorganic and Medicinal Chemistry Letters, 18, 3914–3918. doi:10.1016/j.bmcl.2008.06.039
   PubMed Web of Science ®Google Scholar
• Seelig, A., Gottschlich, R., & Devant, R. M. (1994). A method to determine the ability of drugs to diffuse through the blood-brain barrier. Proceedings of the National Academy of Sciences, 91, 68–72. doi:10.1073/pnas.91.1.68
   PubMed Web of Science ®Google Scholar
• Seidman, A. D. (2003). Monotherapy options in the management of metastatic breast cancer. Seminars in Oncology, 30, 6–10. doi:10.1016/S0093-7754(03)70137-7
   PubMed Web of Science ®Google Scholar
• Seifert, M. H. J., & Lang, M. (2007). Essential factors for successful virtual screening. Mini Reviews in Medicinal Chemistry, 7, 63–72. doi:10.2174/138955708783331540
   Web of Science ®Google Scholar
• Shah, U. A., Deokar, H. S., Kadam, S. S., & Kulkarni, V. M. (2010). Pharmacophore generation and atom-based 3D-QSAR of novel 2-(4-methylsulfonylphenyl)pyrimidines as COX-2 inhibitors. Molecular Diversity, 14, 559–568. doi:10.1007/s11030-009-9183-3
   PubMed Web of Science ®Google Scholar
• Shahrisa, A., Esmati, S., Miri, R., Firuzi, O., Edraki, N., & Nejati, M. (2013). Cytotoxic activity assessment, QSAR and docking study of novel bis-carboxamide derivatives of 4-pyrones synthesized by Ugi four-component reaction. European Journal of Medicinal Chemistry, 66, 388–399. doi:10.1016/j.ejmech.2013.05.049
   PubMed Web of Science ®Google Scholar
• Shankar, R., Chakravarti, B., Singh, U. S., Ansari, M. I., Deshpande, S., Dwivedi, S. K. D., & Hajela, K. (2009). Synthesis and biological evaluation of 3,4,6-triaryl-2-pyranones as a potential new class of anti-breast cancer agents. Bioorganic and Medicinal Chemistry, 17, 3847–3856. doi:10.1016/j.bmc.2009.04.032
   PubMed Web of Science ®Google Scholar
• Shareef, M. A., Duscharla, D., Ramasatyaveni, G., Dhoke, N. R., Das, A., Ummanni, R., & Srivastava, A. K. (2015). Investigation of podophyllotoxin esters as potential anticancer agents: Synthesis, biological studies and tubulin inhibition properties. European Journal of Medicinal Chemistry, 89, 128–137. doi:10.1016/j.ejmech.2014.10.050
   PubMed Web of Science ®Google Scholar
• Stefely, J. A., Palchaudhuri, R., Miller, P. A., Peterson, R. J., Moraski, G. C., Hergenrother, P. J., & Miller, M. J. J. (2010). N-((1-benzyl-1H-1,2,3-triazol-4-yl)methyl)arylamide as a new scaffold that provides rapid access to antimicrotubule agents: Synthesis and evaluation of antiproliferative activity against select cancer cell lines. Journal of Medicinal Chemistry, 53, 3389–3395. doi:10.1021/jm1000979
   PubMed Web of Science ®Google Scholar
• Su, P.-C., Tsai, C.-C., Mehboob, S., Hevener, K. E., & Johnson, M. E. (2015). Comparison of radii sets, entropy, QM methods, and sampling on MM-PBSA, MM-GBSA, and QM/MM-GBSA ligand binding energies of F. tularensis enoyl-ACP reductase (FabI). Journal of Computational Chemistry, 36, 1859–1873. doi:10.1002/jcc.24011
   PubMed Web of Science ®Google Scholar
• Sundarapandian, T., Shalini, J., Sugunadevi, S., & Woo, L. K. (2010). Docking-enabled pharmacophore model for histone deacetylase 8 inhibitors and its application in anti-cancer drug discovery. Journal of Molecular Graphics and Modelling, 29, 382–395. doi:10.1016/j.jmgm.2010.07.007
   PubMed Web of Science ®Google Scholar
• Teli, M. K., & Rajanikant, G. K. (2012). Pharmacophore generation and atom-based 3D-QSAR of N-iso-propyl pyrrole-based derivatives as HMG-CoA reductase inhibitors. Organic and Medicinal Chemistry Letters, 2, 1–10. doi:10.1186/2191-2858-2-25
   PubMedGoogle Scholar
• Telvekar, V. N., Kundaikar, H. S., Patel, K. N., & Chaudhari, H. K. (2008). 3-D QSAR and molecular docking studies on aryl benzofuran-2-yl ketoxime derivatives as Candida albicans N-myristoyl transferase inhibitors. QSAR and Combinatorial Science, 27, 1193–1203. doi:10.1002/qsar.200810017
   Google Scholar
• Tenenhaus, M., Vinzi, V. E., Chatelin, Y.-M., & Lauro, C. (2005). PLS path modeling. Computational Statistics and Data Analysis, 48, 159–205. doi:10.1016/j.csda.2004.03.005
   Web of Science ®Google Scholar
• Veluri, R., Singh, R. P., Liu, Z., Thompson, J. A., Agarwal, R., & Agarwal, C. (2006). Fractionation of grape seed extract and identification of gallic acid as one of the major active constituents causing growth inhibition and apoptotic death of DU145 human prostate carcinoma cells. Carcinogenesis, 27, 1445–1453. doi:10.1093/carcin/bgi347
   PubMed Web of Science ®Google Scholar
• Wang, K., Zhu, X., Zhang, K., Zhu, L., & Zhou, F. (2014). Investigation of gallic acid induced anticancer effect in human breast carcinoma MCF-7 cells. Journal of Biochemical and Molecular Toxicology, 28, 387–393. doi:10.1002/jbt.21575
   PubMed Web of Science ®Google Scholar
• Wang, F., Yang, Z., Liu, Y., Ma, L., Wu, Y., He, L., … Chen, L. (2015). Synthesis and biological evaluation of diarylthiazole derivatives as antimitotic and antivascular agents with potent antitumor activity. Bioorganic and Medicinal Chemistry, 23, 3337–3350. doi:10.1016/j.bmc.2015.04.055
   PubMed Web of Science ®Google Scholar
• Wang, F.-F., Yang, W., Shi, Y.-H., & Le, G.-W. (2016). In silico study on β-aminoketone derivatives as thyroid hormone receptor inhibitors: a combined 3D-QSAR and molecular docking study. Journal of Biomolecular Structure and Dynamics. Advance online publication. doi:10.1080/07391102.2015.1124806.
   Web of Science ®Google Scholar
• Yang, W., Hu, Y., Yang, Y. S., Zhang, F., Zhang, Y. B., Wang, X. L., & Zhu, H. L. (2013). Design, modification and 3D QSAR studies of novel naphthalin-containing pyrazoline derivatives with/without thiourea skeleton as anticancer agents. Bioorganic and Medicinal Chemistry, 21, 1050–1063. doi:10.1016/j.bmc.2013.01.013
   PubMed Web of Science ®Google Scholar
• Yoshino, M., Haneda, M., Naruse, M., Htay, H. H., Iwata, S., Tsubouchi, R., & Murakami, K. (2002). Prooxidant action of gallic acid compounds: copper-dependent strand breaks and the formation of 8-hydroxy-2’-deoxyguanosine in DNA. Toxicology in Vitro, 16, 705–709. doi:10.1016/S0887-2333(02)00061-9
   PubMed Web of Science ®Google Scholar
• Yoshioka, K., Kataoka, T., Hayashi, T., Hasegawa, M., Ishi, Y., & Hibasami, H. (2000). Induction of apoptosis by gallic acid in human stomach cancer KATO III and colon adenocarcinoma COLO 205 cell lines. Oncology Reports, 7, 1221–1223. doi:10.3892/or.7.6.1221
   PubMed Web of Science ®Google Scholar
• You, B. R., Moon, H. J., Han, Y. H., & Park, W. H. (2010). Gallic acid inhibits the growth of HeLa cervical cancer cells via apoptosis and/or necrosis. Food and Chemical Toxicology, 48, 1334–1340. doi:10.1016/j.fct.2010.02.034
   PubMed Web of Science ®Google Scholar
• You, B. R., Kim, S. Z., Kim, S. H., & Park, W. H. (2011). Gallic acid-induced lung cancer cell death is accompanied by ROS increase and glutathione depletion. Molecular and Cellular Biochemistry, 357, 295–303. doi:10.1007/s11010-011-0900-8
   PubMed Web of Science ®Google Scholar
• Youngren, J. F., Gable, K., Penaranda, C., Maddux, B. A., Zavodovskaya, M., Lobo, M., … Goldfine, I. D. (2005). Nordihydroguaiaretic acid (NDGA) inhibits the IGF-1 and c-erbB2/HER2/neu receptors and suppresses growth in breast cancer cells. Breast Cancer Research and Treatment, 94, 37–46. doi:10.1007/s10549-005-6939-z
   PubMed Web of Science ®Google Scholar
• Zavodovskaya, M., Campbell, M. J., Maddux, B. A., Shiry, L., Allan, G., Hodges, L., … Goldfine, I. D. (2008). Nordihydroguaiaretic acid (NDGA), an inhibitor of the HER2 and IGF-1 receptor tyrosine kinases, blocks the growth of HER2-overexpressing human breast cancer cells. Journal of Cellular Biochemistry, 103, 624–635. doi:10.1002/jcb.21435
   PubMed Web of Science ®Google Scholar
• Zeng, L., Holly, J. M., & Perks, C. M. (2014). Effects of physiological levels of the green tea extract epigallocatechin-3-gallate on breast cancer cells. Frontiers in Endocrinology (Lausanne), 5, 61. doi:10.3389/fendo.2014.00061
   PubMed Web of Science ®Google Scholar
• Zhou, J., Yao, J., & Joshi, H. C. (2002). Attachment and tension in the spindle assembly checkpoint. Journal of Cell Science, 115, 3547–3555. doi:10.1242/jcs.00029
   PubMed Web of Science ®Google Scholar
• Zhu, T., Cao, S., Su, P.-C., Patel, R., Shah, D., Chokshi, H. B., … Hevener, K. E. (2013). Hit identification and optimization in virtual screening: practical recommendations based on a critical literature analysis. Journal of Medicinal Chemistry, 56, 6560–6572. doi:10.1021/jm301916b.
   PubMed Web of Science ®Google Scholar